Published in Cancer Weekly, June 29th, 1998
Pedro Politi, representing colleagues from the University of Buenos Aires Medical School, Argentina, and the South American Office for Anticancer Drug Development, Brazil, explained why the group tested T as a therapy for KS at the 34th Annual Meeting of the American Society of Clinical Oncology, held May 16-19, 1998, in Los Angeles, California (abstract "Phase I Trial of Thalidomide in AIDS-Related Kaposi's Sarcoma").
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.